Michael John Rivera-Robles

1PUBLICATIONS
0CO-AUTHORS
Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 04, 2018
Targeting Cdc42 with the anticancer compound MBQ-167 inhibits cell polarity and growth in the budding yeast S. cerevisiae.

Michael John Rivera-Robles, Julia Medina-Velázquez, Gabriela M Asencio-Torres

Pageof 1

Frequent Collaborators